The comparative efficacy and tolerability of the latest fluoroquinolones in pediatric ophthalmology
- Authors: Vorontsova T.N.1, Mikhailova M.V.2, Smoljaninova T.V.1, Brzheskiy V.V.1
-
Affiliations:
- Saint-Petersburg State Pediatric Medical University
- Ophthalmologist. State Center N 7 (ophthalmological)
- Issue: Vol 4, No 2 (2013)
- Pages: 32-36
- Section: Articles
- URL: https://journals.eco-vector.com/pediatr/article/view/1098
- DOI: https://doi.org/10.17816/PED4232-36
- ID: 1098
Cite item
Abstract
Keywords
Full Text
About the authors
Tatiana Nikolaevna Vorontsova
Saint-Petersburg State Pediatric Medical University
Email: vorontsoff@bk.ru
MD, PhD, Associate Professor Department of Ophthalmology with clinical pharmacology course
Maria Vitalievna Mikhailova
Ophthalmologist. State Center N 7 (ophthalmological)
Email: mikhailov@yandex.ru
MD
Tatiana Vyacheslavovna Smoljaninova
Saint-Petersburg State Pediatric Medical University
Email: Da.sm@mail.ru
head of bacteriological laboratory
Vladimir Vsevolodovich Brzheskiy
Saint-Petersburg State Pediatric Medical University
Email: vbrzh@yandex.ru
MD, PhD, Professor, head of Department of Ophthalmology with clinical pharmacology course
References
- Bertino J. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. // Clin. Ophthalmol. — 2010. — Vol. 3. — P. 507–521.
- Castillo A., Benitez del Castillo J. M., Toledano N. et al. Deposits of topical norfloxacin in the treatment of bacterial keratitis. // Cornea. — 1997. — Vol. 16, N 4. — P. 420.
- Eiferman R. A., Snyder J. P., Nordquist R. E. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. // J. Cataract. Refract. Surg. — 2001. — Vol. 27, N 10. — P.1701–1702.
- Hwang D. G., Schanzlin D. J., Rotberg M. H. et al. A phase III, placebo controlled clinical trial of 0,5% Levofloxacin Ophthalmic Solution for the treatment of bacterial conjunctivitis. // Brit. J. Ophthalmol. — 2003. — Vol. 87. — P. 1004–1009.
- Neu H. C. Microbiologic aspects of fluoroquinolones. // Amer. J. Ophthalmol. — 1991. — Vol. 112, N 4. — P. 15–24.
- Ogawa G., Hyndiuk R. The fluoroquinolones: New antibiotics in ophthalmology. // Int. Ophthalmol. Clin. — 1993. — Vol. 33. — P. 59–68.
- Рatwardhan A., Khan M. Topical ciprofloxacin can delay recovery from viral ocular surface infections. // J. R. Soc.Med. — 2005. — Vol. 98. — P.274–275.
- Skelnik D. L., Clark L. A., Bezwada P. Effect of drug concentration and exposure time of levofloxacin, ofloxacin, ciprofloxacin, gatifloxacin, and moxifloxacin on human corneal endothelial cells and keratocytes. Paper presenetd at ARVO Annual Meeting: May 4–9, 2003. Ft. Lauderdale Convention Center.
- Wilhelmus K. R., Abshire R. L. Corneal ciprofloxacin precipitation during bacterial keratitis. // Amer. J. Ophthalmol. — 2003. — Vol. 136, N 6. — P. 1032–1037.
- Watanabe R., Nakazawa T., Yokokura S. Fluoroquinolone antibacterial eye drop: effects on normal corneal epithelium, stroma and endothelium. // Clin. Ophthalmol. — 2010. — Vol. 4. — P. 1181–1187.